Nuvectis Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVCT and other ETFs, options, and stocks.

About NVCT

Nuvectis Pharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology. Its product pipeline includes NXP800 and NXP900. 

CEO
Ronald E. Bentsur
CEORonald E. Bentsur
Employees
13
Employees13
Headquarters
Fort Lee, New Jersey
HeadquartersFort Lee, New Jersey
Founded
2020
Founded2020
Employees
13
Employees13

NVCT Key Statistics

Market cap
207.68M
Market cap207.68M
Price-Earnings ratio
-9.12
Price-Earnings ratio-9.12
Dividend yield
Dividend yield
Average volume
143.01K
Average volume143.01K
High today
$10.32
High today$10.32
Low today
$9.87
Low today$9.87
Open price
$9.95
Open price$9.95
Volume
17.76K
Volume17.76K
52 Week high
$11.80
52 Week high$11.80
52 Week low
$4.44
52 Week low$4.44

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own NVCT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.